Semaglutide is used to treat Type 2 diabetes mellitus as monotherapy (if metformin inappropriate), or in combination with other antidiabetic drugs (including insulin) if existing treatment fails to achieve adequate glycaemic control
doi:10.1136/bmj.322.7297.1271
References For Further Reading (1) D Micic 1, V Popovic, A Kendereski, D Macut (1995) Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood Clinical Endocrinology (Oxford), 1995 Feb, Volume 42 (Issue 2), Pages 191-4
The name reflects the three amino acids that form the peptide structure: Glycine Histidine Lysine Although GHK itself is biologically active, its most studied and therapeutically relevant form is GHK-Cu, which is formed when the peptide binds with a copper ion
In recent years, medical weight loss treatments have taken a revolutionary turn